Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
C4 Therapeutics
3142
C4 Therapeutics
Health Care
Medical
Therapeutics
Diagnostics
C4 Therapeutics, Inc., a Watertown, Mass.-based biotechnology company pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation
Suggest edits
Type
B2b
Founded
2015
Raised
$243M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Biogen
Xconomy
HubSpot
Money Mover
Formlabs
Akamai
General Catalyst
Companies in the same industry
MYi Diagnostics
Anvajo
Enterprise Therapeutics
Thuja Capital
Sphere Fluidics Ltd
HalioDx
Immatics
Promethera Biosciences
Codiak Biosciences
Rani Therapeutics
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$150,000,000
Venture capital (Series B) - 2020
Adage Capital Management
RA Capital Management
Perceptive Advisors
+16
$20,000,000
Debt financing - 2020
Perceptive Advisors
Team Size
2
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
Pulse 2.0
C4 Therapeutics (CCCC) Stock: $15 Price Target From BofA
$150,000,000
Venture capital (Series B)
FinSMEs
,
Pulse 2.0
C4 Therapeutics Raises $170M in Funding
$73,000,000
Venture capital (Series A)
FinSMEs
C4 Therapeutics Closes $73M Series A Financing
Science
Health
Funding
